ANGELA GAINER: Open Payments
NPI 1275159634 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 16 payments from 10 companies in 2025. Trend: 2023 $404 · 2024 $580 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| ABBVIE INC. | 3 | $73 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| PFIZER INC. | 2 | $38 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Baxter Healthcare | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Amgen Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $16 |
Products named: NUZYRA, AIRSUPRA, REXULTI, PREVNAR 20, UBRELVY, QULIPTA, GARDASIL 9, TISSEEL.
Industry payments across OK — which companies pay providers there.
